If you need more lookups,
subscriptions start at $34 USD/month.
Grasiela Willmbrink Location
Melbourne, VIC, AU
Grasiela Willmbrink Work
Senior Scientist @ (August 2019 - Present)
Analytical Development Chemist @ (August 2015 - August 2019)
Chemical Analyst @ Advent Pharmaceuticals Pty Ltd. (August 2014 - August 2015)
Scientist II Research and Development @ (March 2006 - February 2014)
Biochemist @ Red Cross Hospital (January 2005 - December 2005)
Biochemist @ Hospital Geral de Curitiba (June 2004 - December 2004)
Research Scientist @ (August 2001 - July 2004)
Grasiela Willmbrink Education
Universidade Federal do Paraná
Bachelor of Pharmacy - BPharm (Pharmaceutical Sciences)
2000-2005
Grasiela Willmbrink Skills
Brazilian Portuguese
High-Performance Liquid Chromatography (HPLC)
GMP
Microsoft Office
Microsoft Excel
Microsoft Word
Research
Microsoft PowerPoint
Spanish
Lean Six Sigma
Gas Chromatography
UV/Vis Spectroscopy
Report Writing
IR Spectroscopy
Empower
Chemstation
Analytical Method Validation
Cleaning Validation
Method Development
Team Leadership
Process Validation
New Product Validation
Formulation Development
Product Development
Dissolution Testing
Good Laboratory Practice (GLP)
U.S. Food and Drug Administration (FDA)
ANVISA
Atomic Absorption
validation protocol writing
Pharmaceutical Industry
Project Management
TGA
Grasiela Willmbrink Summary
Grasiela Willmbrink, based in Melbourne, VIC, AU, is currently a Senior Scientist at Acrux. Grasiela Willmbrink brings experience from previous roles at IDT Australia Limited, Advent Pharmaceuticals Pty Ltd., Johnson & Johnson and Red Cross Hospital. Grasiela Willmbrink holds a 2000 - 2005 Bachelor of Pharmacy - BPharm in Pharmaceutical Sciences @ Universidade Federal do Paraná. With a robust skill set that includes Brazilian Portuguese, High-Performance Liquid Chromatography (HPLC), GMP, Microsoft Office, Microsoft Excel and more. Grasiela Willmbrink has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Grasiela Willmbrink?
Find contact details for 700 million professionals.